Direct medical cost analysis of breast cancer treatment at Jimma University Medical Center: a provider perspective

The hospital's direct medical costs associated with breast cancer disease were extensive. The highest medical cost was incurred in stage III of the disease. The main cost drivers at JUMC were drugs for chemotherapy, laboratory tests, and radiotherapy (radiologic imaging) added higher direct medical costs followed by surgery and pathology. The stage-specific cost analysis study focused on cost identification and valuation that provides profound information related to the estimation of direct medical cost, and the main cost drivers of the disease, and helps to encourage the treatment and diagnosis of breast cancer at an early stage of the disease.